Ascensia Diabetes Care, a global diabetes care company based in Parsippany, announced Monday that its Eversense Continuous Glucose Monitoring system, the Eversense CGM app, has been updated globally to seamlessly integrate with Apple Health. www.ascensia.com/eversense
This means that people with diabetes using Eversense CGM Systems now also will have the option to view their glucose data within the Apple Health app, alongside other health metrics on the iPhone’s widely used health and wellbeing platform.
Developed by Senseonics Holdings, company officials say the fully implantable Eversense E3 is the longest-lasting CGM available, with up to a 6-month sensor wear duration. The system transmits data to the Eversense CGM App where users can easily view, analyse and share glucose data, and are alerted to changes and trends.
With this update, users in all markets where Eversense is available can now choose to display their data in Apple Health, where they will also be able to view health data collected by their iPhone through various apps and wearables. This integration aims to improve diabetes management by allowing Eversense users to easily view their glucose data within their wider digital health environment.
Elaine Anderson, head of the Eversense CGM business unit, siad the integration will give users more choices.
“Supplementing the benefits of the Eversense CGM App, this update allows people with diabetes to access glucose data alongside other important metrics to provide a more holistic view of their health and wellbeing,” she said. “In an increasingly digital world, it is important that medical devices and digital solutions are interoperable, and we are excited to further embed Eversense into the connected health care ecosystem.”
